Pines Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Pines Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$203K	Buy	+408	New	+$181K	0.06%	217
2025 Q2	–	Sell	-435	Closed	-$205K	–	235
2025 Q1	$205K	Buy	+435	New	+$203K	0.1%	193

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Pines Wealth Management's VRTX Position: Q2 2026 in Review

Pines Wealth Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 408 shares worth $203K. The stake represents 0.06% of the portfolio and ranks #217 among its holdings. This is a return to the name: Pines Wealth Management previously reported a position in VRTX as recently as Q1 2025.

Pines Wealth Management first reported a position in VRTX in Q1 2025 and has held it in 2 quarters since. The position peaked at $205K in Q1 2025. 484 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Pines Wealth Management held 408 shares of Vertex Pharmaceuticals worth $203K as of Q2 2026.
Vertex Pharmaceuticals was a new Pines Wealth Management position in Q2 2026.
Vertex Pharmaceuticals made up 0.06% of Pines Wealth Management's portfolio in Q2 2026, its #217 holding.
Pines Wealth Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
Pines Wealth Management's Vertex Pharmaceuticals position peaked at $205K in Q1 2025.
484 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Pines Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.